X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs TORRENT PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH TORRENT PHARMA STERLING BIOTECH/
TORRENT PHARMA
 
P/E (TTM) x -1.6 28.5 - View Chart
P/BV x 0.1 5.4 1.2% View Chart
Dividend Yield % 0.0 1.0 -  

Financials

 STERLING BIOTECH   TORRENT PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
TORRENT PHARMA
Mar-17
STERLING BIOTECH/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs111,768 0.6%   
Low Rs31,186 0.3%   
Sales per share (Unadj.) Rs26.8346.1 7.7%  
Earnings per share (Unadj.) Rs-15.055.2 -27.1%  
Cash flow per share (Unadj.) Rs-5.573.3 -7.5%  
Dividends per share (Unadj.) Rs014.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs54.9257.1 21.3%  
Shares outstanding (eoy) m267.87169.22 158.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.3 6.1%   
Avg P/E ratio x-0.526.8 -1.7%  
P/CF ratio (eoy) x-1.320.1 -6.3%  
Price / Book Value ratio x0.15.7 2.2%  
Dividend payout %025.4 0.0%   
Avg Mkt Cap Rs m1,862249,887 0.7%   
No. of employees `0001.411.8 11.5%   
Total wages/salary Rs m5479,934 5.5%   
Avg. sales/employee Rs Th5,303.34,971.5 106.7%   
Avg. wages/employee Rs Th403.8843.2 47.9%   
Avg. net profit/employee Rs Th-2,959.0792.4 -373.4%   
INCOME DATA
Net Sales Rs m7,18158,569 12.3%  
Other income Rs m432,233 1.9%   
Total revenues Rs m7,22360,802 11.9%   
Gross profit Rs m94713,773 6.9%  
Depreciation Rs m2,5433,069 82.9%   
Interest Rs m4,3772,056 212.9%   
Profit before tax Rs m-5,93110,881 -54.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9241,545 -124.5%   
Profit after tax Rs m-4,0079,336 -42.9%  
Gross profit margin %13.223.5 56.1%  
Effective tax rate %32.414.2 228.5%   
Net profit margin %-55.815.9 -350.0%  
BALANCE SHEET DATA
Current assets Rs m14,33553,841 26.6%   
Current liabilities Rs m49,80931,612 157.6%   
Net working cap to sales %-494.038.0 -1,301.6%  
Current ratio x0.31.7 16.9%  
Inventory Days Days40397 415.1%  
Debtors Days Days17184 203.7%  
Net fixed assets Rs m55,43242,079 131.7%   
Share capital Rs m268846 31.7%   
"Free" reserves Rs m13,93542,655 32.7%   
Net worth Rs m14,70143,501 33.8%   
Long term debt Rs m9,47822,408 42.3%   
Total assets Rs m73,988101,250 73.1%  
Interest coverage x-0.46.3 -5.6%   
Debt to equity ratio x0.60.5 125.2%  
Sales to assets ratio x0.10.6 16.8%   
Return on assets %0.511.3 4.5%  
Return on equity %-27.321.5 -127.0%  
Return on capital %-6.419.6 -32.7%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,86020,066 9.3%   
Fx outflow Rs m255,304 0.5%   
Net fx Rs m1,83514,762 12.4%   
CASH FLOW
From Operations Rs m1,71910,127 17.0%  
From Investments Rs m-3,148-7,869 40.0%  
From Financial Activity Rs m1,426-1,918 -74.3%  
Net Cashflow Rs m-3212 -1.6%  

Share Holding

Indian Promoters % 33.9 71.5 47.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 7.0 -  
FIIs % 9.9 12.6 78.6%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 8.8 446.6%  
Shareholders   21,482 26,511 81.0%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   BIOCON LTD  WOCKHARDT LTD.  VENUS REMEDIES  SHASUN PHARMA  PIRAMAL ENTERPRISES  

Compare STERLING BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 19, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - PANACEA BIOTECH COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS